Recherche Recherche de structure
wx_img
Inquiry Form
  1. Home
  2. Iptacopan

Iptacopan

Iptacopan is the first oral targeted inhibitor of complement system regulator factor B, which blocks the alternative pathway amplification cycle by inhibiting factor B, and is used to treat complement-driven renal disease (CARD).

4-bromobenzonitrile
4-bromobenzonitrile
CM303430
623-00-7
4-Methoxypyridine
4-Methoxypyridine
CM102692
620-08-6
benzyl 2-(4-cyanophenyl)-4-oxo-1,2,3,4-tetrahydropyridine-1-carboxylate
benzyl 2-(4-cyanophenyl)-4-oxo-1,2,3,4-tetrahydropyridine-1-carboxylate
CM1045802
1644667-44-6
benzyl 4-[(tert-butyldiphenylsilyl)oxy]-2-(4-cyanophenyl)piperidine-1-carboxylate
benzyl 4-[(tert-butyldiphenylsilyl)oxy]-2-(4-cyanophenyl)piperidine-1-carboxylate
CM1046475
2760791-75-9
benzyl 2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate
benzyl 2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate
CM1045816
2367602-96-6
methyl 4-(4-ethoxypiperidin-2-yl)benzoate
methyl 4-(4-ethoxypiperidin-2-yl)benzoate
CM1046476
2920413-89-2
tert-butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate
tert-butyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate
CM148829
1481631-51-9